Skip to main content
logo
Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
20.72
-0.05 (-0.24%)
At close: Oct 15, 2026, 4:00 PM EDT
20.75
+0.03 (0.14%)
After-hours: Oct 15, 2026, 7:51 PM EDT

Scribe Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Market Capitalization
392--
Market Cap Growth
---
Enterprise Value
393--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Debt / Equity Ratio
-0.97-1.80-7.57
Net Debt / Equity Ratio
-0.010.7211.54
Net Debt / EBITDA Ratio
-0.010.721.59
Net Debt / FCF Ratio
-0.010.361.36
Asset Turnover
-0.50-
Quick Ratio
0.560.953.10
Current Ratio
0.570.973.15
Return on Assets (ROA)
--15.80%-
Return on Capital Employed (ROCE)
147.80%-284.50%-46.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Buyback Yield / Dilution
--1.39%-
SEC Filings: 10-K · 10-Q